📰 Robert Steen News
Robert Steen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Steen. Real-time updates on events, politics, business and more.
May 23, 2024
Toronto, Ontario--(Newsfile Corp. - May 23, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development
May 23, 2024
PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approved drugs, is pleased...
May 1, 2024
PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously...
March 13, 2024
PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approved drugs, is pleased...
March 9, 2024
Breaking News, Sports, Manitoba, Canada
February 27, 2024
PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously...
February 11, 2024
The United States is grappling with a relentless surge in fentanyl-related overdose deaths, marking a grim chapter in the ongoing battle against opioid addiction. As the fourth wave of the opioid epidemic crashes through communities nationwide, the devastating toll of fentanyl misuse has left families shattered and communities reeling.
January 28, 2024
Sundance Film Festival announces 2024 awards.
December 13, 2023
PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously...
December 13, 2023
PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) said it plans to continue to carry out Securedose Synthetics’ strategy of developing synthetic formulations of...